Search
Insulet Corp
PODDAdd to Watchlist
153.610USD
+3.930+2.63%
Close 11-02 16:00（ET）
10.65BMarket Cap
35.63P/E TTM
Insulet Corp (PODD) Stock Price Target & Forecast
Analyst Rating
Based on 26 analysts giving stock ratings to Insulet Corp in the past month.
Buy
7 Strong Buy
7 Buy
12 Hold
0 Sell
0 Strong Sell
Target Price
176.926USD+18.80%
PODD Analyst Recommendation Trends
In the current month, PODD has received 7 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. PODD average Analyst price target in the last month is 176.926.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
7
7
7
10
10
10
10
11
7
7
8
12
15
15
14
15
12
12
12
5
4
3
3
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
26
26
27
27
29
28
28
28
PODD Analyst Rating for Peer Comparison
Updated: Nov 1, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Medtronic PLC
MDT
9
11
11
0
0
31
Stryker Corp
SYK
11
13
7
0
0
31
Dexcom Inc
DXCM
13
14
3
0
0
30
Abbott Laboratories
ABT
10
13
6
0
0
29
Zimmer Biomet Holdings Inc
ZBH
2
6
20
0
0
28
Guardant Health Inc
GH
12
14
2
0
0
28
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Tandem Diabetes Care Inc
TNDM
5
8
11
0
0
24
Repligen Corp
RGEN
5
12
4
0
0
21
Alcon AG
ALC
6
9
3
1
0
19
Financial Forecasting
Based on analysts' estimates, PODD EPS is projected to reach 1.587 in FY2026Q3, following reported EPS of 1.371 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.45
1.20
1.45
1.59
1.85
Actual
1.44
1.30
1.37
--
--
Surprise
-0.70%
+8.64%
-5.49%
--
--
FAQs
What is Insulet Corp's expected revenue for the next quarter?
Insulet Corp's expected revenue is 832.69M.
What is Insulet Corp's price target?
Analysts forecast that Insulet Corp's price target is USD 176.93, with the highest forecast at USD 370.00 and the lowest forecast at USD 144.00.
How have Insulet CorpPODD's recent earnings per share performed?
The market expectation was USD 1.37, while Insulet CorpPODD's earnings per share (EPS) for the previous quarter was USD 1.30. EPS for the next quarter is expected at USD 1.59.
What is the analyst rating for Insulet Corp?
Based on the ratings of Insulet Corp's stock from 26 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.